featured
Oncotype DX Score in Management of T1 ER-Positive, HER2-Negative, Lymph Node–Negative Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Breast Cancer Research and Treatment
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Utility of Oncotype DX score in clinical management for T1 estrogen receptor positive, HER2 negative, and lymph node negative breast cancer
Breast Cancer Res Treat 2022 Jan 27;[EPub Ahead of Print], TTA Nguyen, LM Postlewait, C Zhang, JL Meisel, R O'Regan, S Badve, K Kalinsky, X LiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.